成人粒状细胞瘤患者中FOXL2突变循环瘤DNA的预后价值

Geertruid J Brink1, Nizar Hami2, Hans W Nijman3

  • 1Department of Gynecologic Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.

Cancers
|June 13, 2025
PubMed
概括

FOXL2循环瘤DNA (ctDNA) 显示为成人型粒状细胞瘤 (aGCT) 的预后生物标志物具有前景. 可检测到的FOXL2ctDNA表明生存率更差,潜在的残留疾病最小,有助于识别高风险患者.